drugset / Trial / NCT02569554
PPI And Food Effect Study For PF-06463922 In Healthy Volunteers
CrossoverOpen-labelBasic science
Summary
The current study will be conducted in healthy adult subjects to evaluate the effect of proton pump inhibitor and food on pharmacokinetics of PF-06463922, to evaluate the bioavailability of the oral solution relative to the tablet formulation of PF-06463922.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorlatinib | Small molecule | 100 mg | Oral |
| Subject | Rabeprazole | Small molecule | 20 mg | Oral |
Indications
No indication recorded.